Salona Global Further Expands Product Line with Distribution Agreement with Hyperice; Secures Sales Order of Recently Acquired IP with the Mio-Guard Premium Electrode

SAN DIEGO, June 29, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD,” or the ‎‎“Company”) (TSXV:SGMD.VN) announced today it has expanded its product line with an agreement to distribute the Hyperice™ suite of products. Additionally, Salona Global also announced receipt of its first orders of 600 units for the recently launched Mio-Guard® premium reusable electrode based on the acquisition of intellectual property (“IP”) previously announced on April 14, 2022.